I agree that this site is using cookies. You can find further informations here.
X
Terzi, Murat
278  results:
OpenAccess-fulltext X
Search for persons X
?
1

The risk of secondary progressive multiple sclerosis is geo..:

Sharmin, Sifat ; Roos, Izanne ; Simpson-Yap, Steve...
Brain. -146 : 11 (2023), p. 4633-4644. -Brain. - 0006-8950.  , 2023
Link: https://hdl.handle.net/2..
 
?
2

Variability of the response to immunotherapy among subgroup..:

Diouf, Ibrahima ; Malpas, Charles B ; Sharmin, Sifat...
boreal:276383.  , 2023
Link: http://hdl.handle.net/20..
 
?
3

Newly Diagnosed Tumefactive Demyelinating Lesion and Multip..:

Erdoğan, Tuğba ; Koçer, Belgin ; Şen, Sedat..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461761/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Retrospective analysis of effectiveness of fingolimod in re..:

Tuncer, Aslı ; Kurtuncu, Murat ; Terzi, Murat...
Turkish Journal of Medical Sciences.  , 2023
Link: https://hdl.handle.net/1..
 
?
5

Teriflunomide and Time to Clinical Multiple Sclerosis in Pa..:

Lebrun-Frénay, Christine ; Siva, Aksel ; Sormani, Maria Pia...
info:eu-repo/semantics/altIdentifier/doi/10.1001/jamaneurol.2023.2815.  , 2023
Link: https://hal.science/hal-..
 
?
6

Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrel..:

Zhu, Chao ; Kalincik, Tomas ; Horakova, Dana...
boreal:276415.  , 2023
Link: http://hdl.handle.net/20..
 
?
7

Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrel..:

Zhu, Chao ; Kalincik, Tomas ; Horakova, Dana...
boreal:276415.  , 2023
Link: http://hdl.handle.net/20..
 
?
8

The risk of secondary progressive multiple sclerosis is geo..:

Sharmin, Sifat ; Roos, Izanne ; Simpson-Yap, Steve...
info:eu-repo/semantics/altIdentifier/wos/WOS:001063488100001.  , 2023
Link: https://hdl.handle.net/1..
 
?
9

The Effect of Smoking on Inactivated and mRNA Vaccine Respo..:

Şen, Sedat ; Arslan, Gökhan ; Tütüncü, Melih...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461764/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

The risk of secondary progressive multiple sclerosis is geo..:

Sharmin, Sifat ; Roos, Izanne ; Simpson-Yap, Steve...
https://pure.au.dk/portal/en/publications/4f9bdb24-1943-40ec-9207-75ed7f27b889.  , 2023
Link: https://pure.au.dk/porta..
 
?
11

Comparative effectiveness of cladribine tablets versus othe..:

Spelman, Tim ; Ozakbas, Serkan ; Alroughani, Raed...
boreal:276372.  , 2023
Link: http://hdl.handle.net/20..
 
?
12

Variability of the response to immunotherapy among subgroup..:

Diouf, Ibrahima ; Malpas, Charles B ; Sharmin, Sifat...
EUROPEAN JOURNAL OF NEUROLOGY, 30 (4) , p. 1014 -1024.  , 2023
Link: http://hdl.handle.net/19..
 
?
13

The risk of secondary progressive multiple sclerosis is geo..:

Sharmin, Sifat ; Roos, Izanne ; Simpson-Yap, Steve...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629760/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Disability accrual in primary and secondary progressive mul..:

Harding-Forrester, Sam ; Roos, Izanne ; Nguyen, Ai-Lan...
boreal:276382.  , 2023
Link: http://hdl.handle.net/20..
 
?
15

Teriflunomide and Time to Clinical Multiple Sclerosis in Pa..:

Lebrun-Frénay, Christine ; Siva, Aksel ; Sormani, Maria Pia...
info:eu-repo/semantics/altIdentifier/doi/10.1001/jamaneurol.2023.2815.  , 2023
Link: https://hal.science/hal-..
 
1-15